99 related articles for article (PubMed ID: 26529363)
1. Suppression of RAD21 Induces Senescence of MDA-MB-231 Human Breast Cancer Cells Through RB1 Pathway Activation Via c-Myc Downregulation.
Zhu S; Zhao L; Li Y; Hou P; Yao R; Tan J; Liu D; Han L; Huang B; Lu J; Zhang Y
J Cell Biochem; 2016 Jun; 117(6):1359-69. PubMed ID: 26529363
[TBL] [Abstract][Full Text] [Related]
2. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta enforces senescence in Myc-transformed hematopoietic tumor cells through induction of Mad1 and repression of Myc activity.
Wu S; Hultquist A; Hydbring P; Cetinkaya C; Oberg F; Larsson LG
Exp Cell Res; 2009 Nov; 315(18):3099-111. PubMed ID: 19766114
[TBL] [Abstract][Full Text] [Related]
4. E6AP ubiquitin ligase regulates PML-induced senescence in Myc-driven lymphomagenesis.
Wolyniec K; Shortt J; de Stanchina E; Levav-Cohen Y; Alsheich-Bartok O; Louria-Hayon I; Corneille V; Kumar B; Woods SJ; Opat S; Johnstone RW; Scott CL; Segal D; Pandolfi PP; Fox S; Strasser A; Jiang YH; Lowe SW; Haupt S; Haupt Y
Blood; 2012 Jul; 120(4):822-32. PubMed ID: 22689861
[TBL] [Abstract][Full Text] [Related]
5. Suppression of RAD21 gene expression decreases cell growth and enhances cytotoxicity of etoposide and bleomycin in human breast cancer cells.
Atienza JM; Roth RB; Rosette C; Smylie KJ; Kammerer S; Rehbock J; Ekblom J; Denissenko MF
Mol Cancer Ther; 2005 Mar; 4(3):361-8. PubMed ID: 15767545
[TBL] [Abstract][Full Text] [Related]
6. BLCAP arrests G₁/S checkpoint and induces apoptosis through downregulation of pRb1 in HeLa cells.
Zhao M; Zhang L; Qiu X; Zeng F; Chen W; An Y; Hu B; Wu X; Wu X
Oncol Rep; 2016 May; 35(5):3050-8. PubMed ID: 26986503
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of PEA-15 reverses G1 arrest, and nuclear and chromatin changes of senescence phenotype via pErk1/2 translocation to nuclei.
Lee YY; Kim HS; Lim IK
Cell Signal; 2015 Jun; 27(6):1102-9. PubMed ID: 25725291
[TBL] [Abstract][Full Text] [Related]
8. RB1 loss induces quiescent state through downregulation of RAS signaling in mammary epithelial cells.
Gong L; Voon DC; Nakayama J; Takahashi C; Kohno S
Cancer Sci; 2024 May; 115(5):1576-1586. PubMed ID: 38468443
[TBL] [Abstract][Full Text] [Related]
9. Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers.
Xu H; Yan M; Patra J; Natrajan R; Yan Y; Swagemakers S; Tomaszewski JM; Verschoor S; Millar EK; van der Spek P; Reis-Filho JS; Ramsay RG; O'Toole SA; McNeil CM; Sutherland RL; McKay MJ; Fox SB
Breast Cancer Res; 2011 Jan; 13(1):R9. PubMed ID: 21255398
[TBL] [Abstract][Full Text] [Related]
10. Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7.
Bao-Lei T; Zhu-Zhong M; Yi S; Jun-Jie Q; Yan D; Hua L; Bin L; Guo-Wei Z; Zhi-Xian S
J Cell Biochem; 2006 Feb; 97(3):561-71. PubMed ID: 16215989
[TBL] [Abstract][Full Text] [Related]
11. Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells.
Moh MC; Zhang T; Lee LH; Shen S
Carcinogenesis; 2008 Dec; 29(12):2298-305. PubMed ID: 18845560
[TBL] [Abstract][Full Text] [Related]
12. Myc down-regulation as a mechanism to activate the Rb pathway in STAT5A-induced senescence.
Mallette FA; Gaumont-Leclerc MF; Huot G; Ferbeyre G
J Biol Chem; 2007 Nov; 282(48):34938-44. PubMed ID: 17913706
[TBL] [Abstract][Full Text] [Related]
13. Mel-18, a polycomb group protein, regulates cell proliferation and senescence via transcriptional repression of Bmi-1 and c-Myc oncoproteins.
Guo WJ; Datta S; Band V; Dimri GP
Mol Biol Cell; 2007 Feb; 18(2):536-46. PubMed ID: 17151361
[TBL] [Abstract][Full Text] [Related]
14. The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity.
Paul I; Ahmed SF; Bhowmik A; Deb S; Ghosh MK
Oncogene; 2013 Mar; 32(10):1284-95. PubMed ID: 22543587
[TBL] [Abstract][Full Text] [Related]
15. ORAI3 silencing alters cell proliferation and cell cycle progression via c-myc pathway in breast cancer cells.
Faouzi M; Kischel P; Hague F; Ahidouch A; Benzerdjeb N; Sevestre H; Penner R; Ouadid-Ahidouch H
Biochim Biophys Acta; 2013 Mar; 1833(3):752-60. PubMed ID: 23266555
[TBL] [Abstract][Full Text] [Related]
16. ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors.
Ciró M; Prosperini E; Quarto M; Grazini U; Walfridsson J; McBlane F; Nucifero P; Pacchiana G; Capra M; Christensen J; Helin K
Cancer Res; 2009 Nov; 69(21):8491-8. PubMed ID: 19843847
[TBL] [Abstract][Full Text] [Related]
17. EYA1's Conformation Specificity in Dephosphorylating Phosphothreonine in Myc and Its Activity on Myc Stabilization in Breast Cancer.
Li J; Rodriguez Y; Cheng C; Zeng L; Wong EYM; Xu CY; Zhou MM; Xu PX
Mol Cell Biol; 2017 Jan; 37(1):. PubMed ID: 27795300
[TBL] [Abstract][Full Text] [Related]
18. MM-1 facilitates degradation of c-Myc by recruiting proteasome and a novel ubiquitin E3 ligase.
Kimura Y; Nagao A; Fujioka Y; Satou A; Taira T; Iguchi-Ariga SM; Ariga H
Int J Oncol; 2007 Oct; 31(4):829-36. PubMed ID: 17786314
[TBL] [Abstract][Full Text] [Related]
19. Context-dependent regulation of the expression of c-Ski protein by Arkadia in human cancer cells.
Nagano Y; Koinuma D; Miyazawa K; Miyazono K
J Biochem; 2010 Apr; 147(4):545-54. PubMed ID: 19959502
[TBL] [Abstract][Full Text] [Related]
20. MYC synergizes with activated BRAFV600E in mouse lung tumor development by suppressing senescence.
Tabor V; Bocci M; Alikhani N; Kuiper R; Larsson LG
Cancer Res; 2014 Aug; 74(16):4222-9. PubMed ID: 24934810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
